BPC-157 Canada: Research Guide for Sourcing & Handling | Prescott Bio

Prescott Bio Editorial · July 18, 2026 ·

• bpc-157
• healing-peptides
• recovery
• canada
• research-guide

Key takeaways

• BPC-157 is a synthetic 15-amino-acid pentadecapeptide studied in pre-clinical cytoprotection and connective-tissue models.
• A useful lot CoA carries HPLC purity ≥98% by area and a mass-spec identity match against theoretical mass.
• Domestic Canadian dispatch (2–4 business days from British Columbia) avoids CBSA holds on cross-border peptide freight.

BPC-157 is a 15-amino-acid pentadecapeptide. This guide covers three things Canadian research buyers ask before ordering: what to check on a lot CoA, how cold-chain works, and where Canadian buyers get it without customs risk.

What is BPC-157, structurally?

BPC-157 is a synthetic pentadecapeptide — a 15-amino-acid sequence with the reported structure derived from a partial fragment of body protection compound (BPC), a protein originally isolated from human gastric juice. The full parent protein was characterized in the pre-clinical gastric-cytoprotection literature; BPC-157 represents the 15-residue segment that has been the focus of most subsequent research work.

The reported activity in pre-clinical literature centres on cytoprotective and angiogenic effects — that is, protection of existing tissue against experimental injury and the promotion of new microvascular growth in connective and epithelial tissue models. Research contexts have included tendon and ligament injury models, gastrointestinal ulcer models, and vascular endothelial assays.

Structurally, BPC-157 is a short linear peptide with no unusual post-translational modifications, which makes it comparatively easy to synthesize to high purity and comparatively stable in lyophilized form. That said, it is still a peptide backbone: it is degradable in solution, sensitive to repeated freeze-thaw cycles, and best kept cold once reconstituted. The reported bioactivity profile in pre-clinical models is why it remains one of the most-requested research peptides in the recovery-intent category.

What does the published pre-clinical literature actually show?

The published research base on BPC-157 spans roughly two decades of pre-clinical work. At a high level, the reported literature covers three main research contexts:

• Musculoskeletal models. A body of pre-clinical work has examined BPC-157 in experimental tendon and ligament injury models, generally reporting effects consistent with the peptide’s cytoprotective and angiogenic characterization.
• Gastrointestinal models. Some of the earliest published work with BPC-157 examined gastric and intestinal ulcer models, tracing back to the peptide’s discovery as a fragment of the parent gastric protection compound.
• Angiogenesis and vascular models. In vitro and in vivo pre-clinical work has examined BPC-157 in vascular endothelial systems, contributing to the reported angiogenic profile.

The research base is pre-clinical and reported. It is not a source of dosing guidance for laboratory work. Researchers designing bench protocols should work from the published pre-clinical papers and their own institutional protocol review; a supplier’s editorial page is not the place to extract dose ranges.

What should a Canadian lab check before ordering BPC-157?

The research-use-only (RUO) framework is the operating context for BPC-157 supply in Canada. Material supplied for RUO purposes is intended for in vitro and pre-clinical laboratory research. It is not sold, labelled, or represented as a therapeutic product, and Canadian suppliers operating under the RUO framework do not provide human-use guidance.

Domestic Canadian dispatch is the practical default for BPC-157 sourcing. Cross-border shipments from US or overseas suppliers into Canada routinely encounter Canada Border Services Agency inspection delays on peptide-classified freight; those delays compound cold-chain risk on a lyophilized peptide that is otherwise straightforward to ship. A domestic Canadian ship-point removes the border variable entirely — typical door-to-door windows are 2-4 business days within Canada.

The documentation side of sourcing also matters. Each lot of BPC-157 should ship with a lot-specific certificate of analysis from the assay lab. Reused template CoAs are not useful for method-development work; researchers doing comparative assays across lots need lot-specific chromatogram data or a summary of peak areas to trace batch-to-batch variation. That documentation is what makes a supply chain useful downstream.

For the domestic supply reference and current lot status, see the BPC-157 Canada lander. It ties together the current CoA, ship-window, and pricing tiers used for Canadian research buyers.

How do I read a BPC-157 CoA — what should be on it?

A BPC-157 certificate of analysis should carry the following core data points. Reading them in order gives you a fast sanity check on whether the lot is worth ordering into your research pipeline.

• HPLC purity. Look for a reported purity figure at or above 98% by HPLC area for a research-grade lot. BPC-157 synthesizes cleanly; sub-98 purity numbers on a research-grade lot are unusual and worth asking about.
• Mass spectrometry confirmation. The observed monoisotopic mass should match the theoretical mass within a small error window — typically well under 0.5 Da for a peptide of this size. Mass confirmation is the primary check that the material in the vial is in fact BPC-157 rather than a truncated or side-product peptide.
• Water content. Karl Fischer or loss-on-drying is helpful for calculating working concentrations from lyophilized mass, especially when comparing across lots.
• Lot number and manufacture date. These should appear on the vial label as well as the CoA.

For the CoA reference standard we use across domestic Canadian dispatch, see the certificate of analysis reference.

How do I store and reconstitute BPC-157?

Lyophilized BPC-157, sealed in the original vial, is stable at 2-8 °C for the window reported by the assay lab — typically at least twelve months for a fresh lot. For longer-term storage beyond six months, laboratories generally transfer sealed vials to -20 °C freezer storage. Keep the vials in original packaging until first use.

Reconstitution is standard. Most laboratory protocols use bacteriostatic water (BAC water) at 1-2 mL per vial, adjusting the reconstitution volume to reach the desired working concentration. Sterile technique matters: the reconstituted working stock is what most bench work draws from, so contamination at reconstitution propagates through every downstream aliquot.

Once reconstituted, the working stability window shortens. Reconstituted BPC-157 is typically stored at 2-8 °C and used within a research-defined window — most published pre-clinical protocols use a 30-day working window at 2-8 °C, with longer-term aliquots frozen at -20 °C. Avoid repeated freeze-thaw cycles on the same aliquot; freeze in single-use volumes rather than one large frozen stock.

For cold-chain during transit, domestic Canadian dispatch typically uses an insulated shipper with phase-change coolant sized for a 48-72 hour window. Confirm the temperature indicator on receipt before signing off on the lot.

Which papers should I read next?

BPC-157 sits alongside two other reference topics we cover on this blog:

• The Retatrutide Canada research guide covers a triple-agonist metabolic-intent peptide with a very different research context, but the CoA-reading and cold-chain sections apply directly in parallel.
• The research peptides regulatory reference is the plain-language explainer for the RUO framework, worth reading once if you’re new to Canadian research-peptide sourcing.

Where can I buy BPC-157 in Canada without cross-border risk?

Prescott Bio supplies BPC-157 from a domestic Canadian ship-point with lot-tested vials and a lot-specific certificate of analysis. Two vial sizes are stocked as standard research SKUs: BPC-157 10mg and BPC-157 5mg. The 10mg format is the most common bench SKU; the 5mg format is used by groups running smaller aliquot volumes or protocol-development work where a smaller working stock is preferred.

BPC-157 typically pairs with other recovery-intent research peptides in comparative pre-clinical work — see the recovery research protocol reference for the standard pairing set, and the BPC-157 Canada lander for the current lot’s CoA and ship-window status.

All BPC-157 supplied through Prescott Bio is for laboratory research use only.